Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 25.43% is in line with its 5-year average of 26.75%, near the high end of its 5-year range (12.20%–29.42%).
0.96% below its 12-month average of 25.68%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
25.43%
EBITDA MARGIN AVG TTM
25.68%
EBITDA MARGIN AVG 3Y
26.03%
EBITDA MARGIN AVG 5Y
26.75%
EBITDA MARGIN AVG 10Y
24.96%
EBITDA MARGIN AVG 15Y
23.12%
EBITDA MARGIN AVG 20Y
21.33%
CURRENT VS TTM AVG
-0.96%
CURRENT VS 3Y AVG
-2.31%
CURRENT VS 5Y AVG
-4.95%
CURRENT VS 10Y AVG
+1.90%
CURRENT VS 15Y AVG
+9.98%
CURRENT VS 20Y AVG
+19.22%
Agilent Technologies, Inc.
Market Cap
$41.48B
EBITDA Margin
25.43%
TTM Avg
25.68%
3Y Avg
26.03%
5Y Avg
26.75%
Market Cap
$41.04B
EBITDA Margin
34.08%
TTM Avg
33.18%
3Y Avg
32.37%
5Y Avg
31.82%
Market Cap
$42.81B
EBITDA Margin
18.31%
TTM Avg
11.44%
3Y Avg
6.73%
5Y Avg
5.67%
Market Cap
$34.80B
EBITDA Margin
15.00%
TTM Avg
4.83%
3Y Avg
-18.55%
5Y Avg
-52.26%
Market Cap
$49.35B
EBITDA Margin
23.08%
TTM Avg
23.14%
3Y Avg
23.23%
5Y Avg
22.53%
Market Cap
$49.93B
EBITDA Margin
29.55%
TTM Avg
28.88%
3Y Avg
30.96%
5Y Avg
31.73%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agilent Technologies, Inc. (A) | $41.48B | 25.43% | 25.68% | 26.03% | 26.75% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $41.04B | 34.08% | 33.18% | 32.37% | 31.82% |
| IQVIA Holdings Inc. (IQV)vs › | $42.67B | 21.04% | 21.29% | 20.90% | 20.09% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.81B | 18.31% | 11.44% | 6.73% | 5.67% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.80B | 15.00% | 4.83% | -18.55% | -52.26% |
| Humana Inc. (HUM)vs › | $48.40B | 1.76% | 1.98% | 3.17% | 4.08% |
| Alcon Inc. (ALC)vs › | $33.71B | 24.53% | 25.59% | 24.02% | 22.67% |
| Becton, Dickinson and Company (BDX)vs › | $49.35B | 23.08% | 23.14% | 23.23% | 22.53% |
| Edwards Lifesciences Corporation (EW)vs › | $49.93B | 29.55% | 28.88% | 30.96% | 31.73% |
| ResMed Inc. (RMD)vs › | $32.06B | 36.98% | 37.16% | 34.64% | 34.36% |
Gross Margin
53.7%
EBITDA Margin
25.4%
Operating Margin
22.2%
Net Margin
19.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-07-31 | 27.16% |
| 2026-04-30 | 25.40% |
| 2026-01-31 | 23.36% |
| 2025-10-31 | 27.62% |
| 2025-07-31 | 24.86% |
| 2025-04-30 | 22.36% |
| 2025-01-31 | 26.65% |
| 2024-10-31 | 28.04% |
| 2024-07-31 | 25.10% |
| 2024-04-30 | 27.08% |
| 2024-01-31 | 26.90% |
| 2023-10-31 | 27.84% |
| 2023-07-31 | 12.20% |
| 2023-04-30 | 26.44% |
| 2023-01-31 | 28.08% |
| 2022-10-31 | 29.42% |
| 2022-07-31 | 28.58% |
| 2022-04-30 | 27.50% |
| 2022-01-31 | 27.36% |
| 2021-10-31 | 28.86% |
| 2021-07-31 | 26.48% |
| 2021-04-30 | 23.93% |
| 2021-01-31 | 26.10% |
| 2020-10-31 | 25.29% |
| 2020-07-31 | 24.35% |
| 2020-04-30 | 14.38% |
| 2020-01-31 | 21.67% |
| 2019-10-31 | 23.85% |
| 2019-07-31 | 21.98% |
| 2019-04-30 | 21.73% |
| 2019-01-31 | 23.68% |
| 2018-10-31 | 23.18% |
| 2018-07-31 | 22.36% |
| 2018-04-30 | 21.56% |
| 2018-01-31 | 23.12% |
| 2017-10-31 | 23.97% |
| 2017-07-31 | 22.62% |
| 2017-04-30 | 23.14% |
| 2017-01-31 | 24.46% |
| 2016-10-31 | 21.51% |
| 2016-07-31 | 19.73% |
| 2016-04-30 | 19.14% |
| 2016-01-31 | 21.50% |
| 2015-10-31 | 20.87% |
| 2015-07-31 | 20.32% |
| 2015-04-30 | 17.65% |
| 2015-01-31 | 17.84% |
| 2014-10-31 | 15.63% |
| 2014-07-31 | 22.70% |
| 2014-04-30 | 19.33% |
| 2014-01-31 | 21.83% |
| 2013-10-31 | 22.12% |
| 2013-07-31 | 19.79% |
| 2013-04-30 | 17.61% |
| 2013-01-31 | 18.51% |
| 2012-10-31 | 21.05% |
| 2012-07-31 | 20.55% |
| 2012-04-30 | 20.83% |
| 2012-01-31 | 20.37% |
| 2011-10-31 | 21.76% |
| 2011-07-31 | 20.34% |
| 2011-04-30 | 19.68% |
| 2011-01-31 | 18.04% |
| 2010-10-31 | 17.13% |
| 2010-07-31 | 12.64% |
| 2010-04-30 | 14.95% |
| 2010-01-31 | 10.96% |
| 2009-10-31 | 9.51% |
| 2009-07-31 | 3.78% |
| 2009-04-30 | -0.64% |
| 2009-01-31 | 5.57% |
| 2008-10-31 | 19.99% |
| 2008-07-31 | 19.04% |
| 2008-04-30 | 16.62% |
| 2008-01-31 | 13.14% |
| 2007-10-31 | 16.46% |
| 2007-07-31 | 15.87% |
| 2007-04-30 | 13.48% |
| 2007-01-31 | 11.02% |
| 2006-10-31 | 18.06% |
| 2006-07-31 | 17.62% |
| 2006-04-30 | 10.90% |
| 2006-01-31 | 6.44% |
| 2005-10-31 | -43.81% |
| 2005-07-31 | 8.18% |
| 2005-04-30 | 7.46% |
| 2005-01-31 | 8.62% |
| 2004-10-31 | 8.51% |
| 2004-07-31 | 9.39% |
| 2004-04-30 | 10.16% |
| 2004-01-31 | 9.74% |
| 2003-10-31 | 8.66% |
| 2003-07-31 | -6.59% |
| 2003-04-30 | -16.02% |
| 2003-01-31 | -12.32% |
| 2002-10-31 | -11.52% |
